SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001421168-12-000003
Filing Date
2012-04-27
Accepted
2012-04-27 19:04:04
Documents
1
Period of Report
2012-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6819
  Complete submission text file 0001421168-12-000003.txt   8427
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMPRIMIS PHARMACEUTICALS, INC. 437 S HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address
Abrams Jeffrey J (Reporting) CIK: 0001421168 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52998 | Film No.: 12791469